- ホーム
- アプリ分析
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar vs DRUGDOCS使用状況と統計
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App ストア
- 有料
- 医学
ストアランキング
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
Biosimilar対DRUGDOCSランキング比較
と過去28日間の Biosimilar ランキング傾向を比較 DRUGDOCS
Biosimilar#132
ランキング
Biosimilar 対 DRUGDOCS 国の比較によるランキング
と過去28日間の Biosimilar ランキング傾向を比較 DRUGDOCS
業界別 ウェブサイトカテゴリー
ご利用可能なデータがありません
医学
無料トライアルで任意のサイトと比較する
Biosimilar VS.
DRUGDOCS
12月 19, 2024